FDA Adverse Event Death Summary report: N

PIPELINE FLEX W/SHIELD TECHNOLOGY

MDR report key: 21093492 · Received January 7, 2025

Report

Report Number
2029214-2025-00066
Event Type
Death
Date Received
January 7, 2025
Date of Event
December 6, 2024
Report Date
August 13, 2025
Manufacturer
MICRO THERAPEUTICS, INC. DBA EV3
Product Code
OUT
UDI-DI
00763000284091
PMA / PMN Number
P100018
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

CONTINUATION OF D10: PRODUCT ID: PED2-325-20 (B621488). MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Additional Manufacturer Narrative · 0

MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Additional Manufacturer Narrative · 0

MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Description of Event or Problem · 0

MEDTRONIC RECEIVED INFORMATION REGARDING A PATIENT WHO HAD TWO PIPELINES OF THE SAME MODEL/LOT IMPLANTED WHO HAD POST-OPERATIVE COMPLICATIONS. IT WAS REPORTED THAT THE TWO PIPELINE FLEX WITH SHIELD STENTS WERE IMPLANTED ON (B)(6) 2024. NO DEVICE MALFUNCTION OR INTRAOPERATIVE ISSUE WAS REPORTED. ON (B)(6) 2024, THE PATIENT WAS HOSPITALIZED AFTER EXPERIENCING FEVER AND PROGRESSIVE DECLINE IN MENTAL STATUS. IMAGING RESULTS WERE SUGGESTIVE OF CONCERN FOR CEREBRAL VASOSPASM ASSOCIATED WITH SUBARACHNOID HEMORRHAGE (SAH) IN EVOLUTION. THE PATIENT UNDERWENT A PROCEDURE FOR INTRAARTERIAL VASODILATOR (VERAPAMIL 20MG) INTERNAL CAROTID ARTERY (ICA) INFUSION WITH MILD IMPROVEMENT AND WAS MONITORED. IT WAS CONSIDERED LIKELY THAT VASOSPASM CAUSED THE SYMPTOMS OF FEVER AND SIMILAR SYMPTOMS TO PNEUMONIA AND SEPTIC SHOCK. THE PATIENT OUTCOME WAS NOTED AS "RECOVERING/RESOLVING." THE EVENT REQUIRED PATIENT HOSPITALIZATION AND INTERVENTION BUT WAS NOT LIFE-THREATENING AND DID NOT RESULT IN PATIENT DISABILITY. SITE ASSESSMENT CONCLUDED THE EVENTS WERE POSSIBLE RELATED TO THE PATIENT DISEASE UNDER STUDY AND/OR THE INDEX PROCEDURE BUT NOT RELATED TO THE IMPLANTED PIPELINES OR ACCESSORY DEVICES.

Description of Event or Problem · 0

ADDITIONAL INFORMATION RECEIVED REPORTED THE EVENT BECAME FATAL ON (B)(6) 2024. SYMPTOMATIC VASOSPASM PDO 5, 8, DCI ON CT POD 18, DEATH SEVERE ADVERSE EVENT CRITERIA ALTHOUGH NOT IMMEDIATE CAUSE OF DEATH, THE VASOSPASM AND DCI MAY HAVE CONTRIBUTED TO PROLONGED INTUBATION AND ARDS.

Description of Event or Problem · 0

ADDITIONAL INFORMATION RECEIVED REPORTED THAT THE EVENT WAS CAUSALLY RELATED TO THE DISEASE UNDER STUDY. THE SITE WAS QUERIED TO CONFIRM IF MULTIPLE DEVICES WERE USED. AVAILABLE SOURCE DOCUMENT ONLY MENTIONS ONE STUDY DEVICE IMPLANTATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1322204 PIPELINE FLEX W/SHIELD TECHNOLOGY INTRACRANIAL ANEURYSM FLOW DIVERTER OUT MICRO THERAPEUTICS, INC. DBA EV3 PED2-325-20 B621488 00763000284091

Patients

Seq Age Sex Outcome Treatment
1 61 YR Female Hospitalization| D| R SEE H11.